@article{TLCR19972,
author = {Lore Decoster and Philippe Giron and Sacha Mignon and Jacques De Grève},
title = {The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {The current standard first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harbouring an epidermal growth factor receptor (EGFR) mutation is a first or second-generation EGFR tyrosine kinase inhibitor (TKI) (1,2).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/19972}
}